Company intelligence / Profile preview
Chinoin
Budapest, Budapest, Hungarychinoin.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Chinoin has a long history as an innovative pharmaceutical manufacturer with significant R&D achievements in Hungary during the twentieth century—pioneering industrial synthesis of papaverine and sulfonamides—and remains a major producer under Sanofi ownership. The Mexican company operates independently as a leading domestic pharma manufacturer focused on high-quality generic medicines for human and veterinary use with advanced manufacturing capabilities including continuous processing.
- Therapeutic areas
- EndocrinologyOtherPsychiatryCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculesOral solid dosage formsVeterinary medicines
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Historical joint venture with French firm pre-Sanofi acquisition
Beyond the preview
Go deeper on Chinoin.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chinoin.